↓ Skip to main content

Dove Medical Press

Article Metrics

Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk

Overview of attention for article published in Vascular Health and Risk Management, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
1 blog
twitter
3 tweeters
patent
1 patent

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
21 Mendeley
Title
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
Published in
Vascular Health and Risk Management, July 2013
DOI 10.2147/vhrm.s34421
Pubmed ID
Authors

Honglin Hu, Zou

Abstract

Pioglitazone and other thiazolidinediones (TZDs) initially showed great promise as unique receptor-mediated oral therapy for type 2 diabetes, but a host of serious side effects, primarily cardiovascular, have limited their utility. It is crucial at this point to perform a risk- benefit analysis to determine what role pioglitazone should play in our current treatment of type 2 diabetes and where the future of this class of drugs is headed. This review provides a comprehensive overview of the present literature. Clinical data currently available indicate that pioglitazone is an effective and generally well-tolerated treatment option for use in patients with type 2 diabetes. Pioglitazone can still reduce adverse cardiovascular risk.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 24%
Student > Bachelor 3 14%
Researcher 3 14%
Student > Ph. D. Student 2 10%
Lecturer 2 10%
Other 2 10%
Unknown 4 19%
Readers by discipline Count As %
Medicine and Dentistry 10 48%
Agricultural and Biological Sciences 2 10%
Biochemistry, Genetics and Molecular Biology 1 5%
Nursing and Health Professions 1 5%
Engineering 1 5%
Other 0 0%
Unknown 6 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2020.
All research outputs
#1,941,654
of 17,549,474 outputs
Outputs from Vascular Health and Risk Management
#52
of 643 outputs
Outputs of similar age
#19,316
of 166,509 outputs
Outputs of similar age from Vascular Health and Risk Management
#3
of 24 outputs
Altmetric has tracked 17,549,474 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 643 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,509 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.